---
title: How do we measure the costs, benefits, and harms of sharing data from biomedical
  studies? A protocol for a scoping review
date: '2025-01-27'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39867822/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20250127170523&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSION: Research participants, investigators, regulatory groups,
  ethics review committees, data protection officers, and funders cannot make informed
  decisions or policies about data reuse without appropriate means of measuring the
  effects, positive or negative, and cost of data ...'
disable_comments: true
---
CONCLUSION: Research participants, investigators, regulatory groups, ethics review committees, data protection officers, and funders cannot make informed decisions or policies about data reuse without appropriate means of measuring the effects, positive or negative, and cost of data ...